1. Home
  2. BNED vs LRMR Comparison

BNED vs LRMR Comparison

Compare BNED & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNED
  • LRMR
  • Stock Information
  • Founded
  • BNED 1965
  • LRMR N/A
  • Country
  • BNED United States
  • LRMR United States
  • Employees
  • BNED N/A
  • LRMR N/A
  • Industry
  • BNED Other Specialty Stores
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNED Consumer Discretionary
  • LRMR Health Care
  • Exchange
  • BNED Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • BNED 338.8M
  • LRMR 309.8M
  • IPO Year
  • BNED N/A
  • LRMR N/A
  • Fundamental
  • Price
  • BNED $9.44
  • LRMR $4.26
  • Analyst Decision
  • BNED
  • LRMR Strong Buy
  • Analyst Count
  • BNED 0
  • LRMR 7
  • Target Price
  • BNED N/A
  • LRMR $16.71
  • AVG Volume (30 Days)
  • BNED 261.9K
  • LRMR 5.0M
  • Earning Date
  • BNED 09-12-2025
  • LRMR 11-14-2025
  • Dividend Yield
  • BNED N/A
  • LRMR N/A
  • EPS Growth
  • BNED N/A
  • LRMR N/A
  • EPS
  • BNED N/A
  • LRMR N/A
  • Revenue
  • BNED $1,567,800,000.00
  • LRMR N/A
  • Revenue This Year
  • BNED $2.74
  • LRMR N/A
  • Revenue Next Year
  • BNED N/A
  • LRMR N/A
  • P/E Ratio
  • BNED N/A
  • LRMR N/A
  • Revenue Growth
  • BNED N/A
  • LRMR N/A
  • 52 Week Low
  • BNED $7.90
  • LRMR $1.61
  • 52 Week High
  • BNED $14.41
  • LRMR $9.50
  • Technical
  • Relative Strength Index (RSI)
  • BNED 51.36
  • LRMR 49.97
  • Support Level
  • BNED $9.28
  • LRMR $3.88
  • Resistance Level
  • BNED $9.78
  • LRMR $4.99
  • Average True Range (ATR)
  • BNED 0.33
  • LRMR 0.47
  • MACD
  • BNED -0.04
  • LRMR -0.06
  • Stochastic Oscillator
  • BNED 50.19
  • LRMR 61.38

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: